India, May 26 -- Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance its mission of using the power of science to bring new medicines to patients in need.

The Regeneron GCC is expected to grow to hundreds of jobs in the coming years as it expands capabilities across key global functions. Founded and led by physician-scientists, Regeneron is a global biotechnology leader headquartered in the United States (US) with 15 approved or authorised medicines and nearly 50 pipeline candidates spanning multiple therapeutic areas.

The Regeneron GCC is expected to further strengthe...